These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18610753)

  • 1. Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Shin SC; Piao YJ; Choi JS
    In Vivo; 2008; 22(3):391-5. PubMed ID: 18610753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Shin SC; Choi JS
    Anticancer Drugs; 2009 Aug; 20(7):584-8. PubMed ID: 19491656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
    Cho YA; Lee W; Choi JS
    Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
    Shin SC; Choi JS; Li X
    Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.
    Kim CS; Choi SJ; Park CY; Li C; Choi JS
    Anticancer Res; 2010 Jan; 30(1):79-85. PubMed ID: 20150620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by baicalein.
    Li C; Kim M; Choi H; Choi J
    Arch Pharm Res; 2011 Nov; 34(11):1965-72. PubMed ID: 22139696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats.
    Singh SP; Wahajuddin ; Raju KS; Ali MM; Kohli K; Jain GK
    Phytother Res; 2012 Feb; 26(2):303-7. PubMed ID: 22131128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin.
    Choi JS; Kang KW
    Arch Pharm Res; 2008 Dec; 31(12):1631-6. PubMed ID: 19099234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats.
    Piao Y; Shin SC; Choi JS
    Biopharm Drug Dispos; 2008 May; 29(4):245-9. PubMed ID: 18338336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Li C; Lim SC; Kim J; Choi JS
    Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):175-82. PubMed ID: 21442417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats.
    Piao YJ; Choi JS
    J Pharm Pharmacol; 2008 May; 60(5):625-9. PubMed ID: 18416939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
    Choi BC; Choi JS; Han HK
    Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of morin on the pharmacokinetics of etoposide in rats.
    Li X; Yun JK; Choi JS
    Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats.
    Choi HJ; Choi JS
    Arch Pharm Res; 2005 Aug; 28(8):970-6. PubMed ID: 16178425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin.
    Pathak SM; Udupa N
    Biopharm Drug Dispos; 2010 Mar; 31(2-3):202-14. PubMed ID: 20238375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of baicalein, an antioxidant, on the bioavailability of doxorubicin in rats: possible role of P-glycoprotein inhibition by baicalein.
    Shin SC; Li C; Choi JS
    Pharmazie; 2009 Sep; 64(9):579-83. PubMed ID: 19827298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C; Li X; Choi JS
    Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors.
    Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH
    Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
    Singh SP; Wahajuddin ; Ali MM; Kohli K; Jain GK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2845-51. PubMed ID: 21890435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced systemic availability of methotrexate in the presence of morin in rats.
    Hong SS; Jin MJ; Han HK
    Biopharm Drug Dispos; 2008 May; 29(4):189-93. PubMed ID: 18240155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.